CYP17 and tumor necrosis factor-α gene polymorphisms are associated with risk of oral cancer in Chinese patients in Taiwan

Acta Oto-Laryngologica

Volumn 125, Issue 1, 2005, Pages 96-99

  Chen, Wei Cheng ^a   Tsai, Ming Hsui ^a   Wan, Lei ^a   Chen, Wen Chi ^a   Tsai, Chang Hai ^b   Tsai, Fuu Jen ^a,c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cytochrome P450; Polymerase chain reaction; Promoter 308; Restriction enzyme; Single nucleotide polymorphism

Indexed keywords

CYTOCHROME P450 17; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; GENETIC ASSOCIATION; GENETIC CODE; HOMOZYGOTE; HUMAN; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; STEROID METABOLISM; TAIWAN;

ADULT; AGED; ALLELES; CHINA; DNA PRIMERS; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; STEROID 17-ALPHA-HYDROXYLASE; TAIWAN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 12344278923     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480410016919     Document Type: Article

References (25)

1. D'Costa J, Saranath D, Dedhia P, Sanghvi V, Mehta AR. Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol 1998;34:413-20.
2. Sugerman PB, Shillitoe EJ. The high risk human papillomaviruses and oral cancer: evidence for and against a causal relationship. Oral Dis 1997;3:130-47.
3. Picado-Leonard J, Miller WL. Cloning and sequence of the human gene for P450c17 (steroid 17 a-hydroxylase/17,20 lyase): similarity with the gene for p450c21. DNA Cell Biol 1987;6:439-48.
4. Brentano ST, Picado-Leonard J, Mellon SH, Moore CCD, Miller WL. Tissue-specific cyclic adenosine 3′,5′-monophosphate-induced and phorbol ester-repressed transcription from the human P450c17 promoter in mouse cells. Mol Endocrinol 1990;4:1972-9.
5. Nedwin GE, Naylor SL, Sakaguchi AY, Smith D, Jarrett-Nedwin J, Pennica D, et al. Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res 1985;13:6361-73.
6. Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumor necrosis factor-α (TNF-α) gene detectable by Nco I restriction of PCR product. Hum Mol Genet 1992;1:353.
7. Drummond SN, De Marco L, Pordeus Ide A, Barbosa AA, Gomez RS. TP53 codon 72 polymorphism in oral squamous cell carcinoma. Anticancer Res 2002;22:3379-81.
8. Yamazaki Y, Chiba I, Hirai A, Sugiura C, Notani K, Kashiwazaki H, et al. Specific p53 mutations predict poor prognosis in oral squamous cell carcinoma. Oral Oncol 2003;39:163-9.
9. Shwe M, Chiguchi G, Yamada S, Nakajima T, Maung KK, Takagi M, et al. P53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas. J Med Dent Sci 2001;48:113-9.
10. Nagpal JK, Patnaik S, Das BR. Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer 2002;97:649-53.
11. Hsieh LL, Wang PF, Chen IH, Liao CT, Wang HM, Chen MC, et al. Characteristics of mutations in the p53 gene in oral squamous cell carcinoma associated with betel quid chewing and cigarette smoking in Taiwanese. Carcinogenesis 2001;22:1497-503.
12. Tandle AT, Sanghvi V, Saranath D. Determination of p53 genotypes in oral cancer patients from India. Br J Cancer 2001;84:739-42.
13. Heinzel PA, Balaram P, Bernard HU. Mutations and polymorphisms in the p53, p21 and p16 genes in oral carcinomas of Indian betel quid chewers. Int J Cancer 1996;68:420-3.
14. Lin SC, Chang KW, Chang CS, Liu TY, Tzeng YS, Yang FS, et al. Alterations of p16/MTS1 gene in oral squamous cell carcinomas from Taiwanese. J Oral Pathol Med 2000;29:159-66.
15. Gronau S, Koenig-Greger D, Jerg M, Riechelmann H. GSTM1 enzyme concentration and enzyme activity in correlation to the genotype of detoxification enzymes in squamous cell carcinoma of the oral cavity. Oral Dis 2003;9:62-7.
16. Buch SC, Notani PN, Bhisey RA. Polymorphism at GSTM1, GSTM3 and GSTT1 gene loci and susceptibility to oral cancer in an Indian population. Carcinogenesis 2002;23:803-7.
17. Sreelekha TT, Ramadas K, Pandey M, Thomas G, Nalinakumari KR, Pillai MR. Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol 2001;37:593-8.
18. Galbraith GMP, Pandey JP. Tumor necrosis factor alpha (TNF-α) gene polymorphism in alopecia areata. Hum Genet 1995;96:433.
19. Patino-Garcia A, Sotillo-Pineiro E, Modesto C, Sierrasesumaga L. Analysis of the human tumor necrosis factor-alpha (TNF-α) gene promoter polymorphism in children with bone cancer. J Med Genet 2000;37:789.
20. Chiu CJ, Chiang CP, Chang ML, Chen HM, Hahn LJ, Hsieh LL, et al. Association between genetic polymorphism of tumor necrosis factor-alpha and risk of oral submucous fibrosis, a pre-cancerous condition of oral cancer. J Dent Res 2001;80:2055-9.
21. Pindborg JJ, Murti PR, Bhonsle RB, Gupta PC, Daftary DK, Mehta FS. Oral submucous fibrosis as a precancerous condition. Scand J Dent Res 1984;92:224-9.
22. Stanford JL, Noonan EA, Iwasaki L, Kolb S, Chadwick RB, Feng Z, et al. A polymorphism in the CYP17 gene and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2002;11:243-7.
23. Ntais C, Polycarpou A, Ioannidis JP. Association of the CYP17 gene polymorphism with the risk of prostate cancer: a meta-analysis [Review]. Cancer Epidemiol Biomarkers Prev 2003;12:120-6.
24. Haiman CA, Stampfer MJ, Giovannucci E, Ma J, Decalo NE, Kantoff PW, et al. The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer. Cancer Epidemiol Biomarkers Prev 2001;10:743-8.
25. Habuchi T, Liqing Z, Suzuki T, Sasaki R, Tsuchiya N, Tachiki H, et al. Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect. Cancer Res 2000;60:5710-3.